Home
Discover
Research
Finance
Strategy

Get 40% off Premium. Unlock the BEST of AlphaPilot.

Finance
ALZN

Overview Financials Analysis Smart Money

Alzamend Neuro, Inc.

ALZN · NASDAQ

Analyze with AI

Filings1

Total reported value$0.0

Manager	Shares	Value	Change
Kingsbury Capital Investment Advisors LLC	0	$0.0	+100.0%

SymbolALZN

Market Cap$6.7M

IPO Date2021-06-15

CEOStephan Jackman

Employees4

SectorHealthcare

IndustryBiotechnology

CountryUS

ExchangeNASDAQ Capital Market

Radiopharm Theranostics Limited

RADX

$10.69

+150.94%

Artiva Biotherapeutics, Inc.

ARTV

$6.34

+92.12%

Syra Health Corp. Class A Common Stock

SYRA

$0.09

+50.00%

3 E Network Technology Group Ltd Class A Ordinary Shares

MASK

$0.4296

+42.87%

NetClass Technology Inc

NTCL

$0.9449

+38.96%

Peers

BioCardia, Inc.

BCDA · NASDAQ

$1.29

-11.28%

Creative Medical Technology Holdings, Inc.

CELZ · NASDAQ

$2.14

-0.47%

HCW Biologics Inc.

HCWB · NASDAQ

$1.87

+3.09%

Acurx Pharmaceuticals, Inc.

ACXP · NASDAQ

$3.71

-8.85%

Aprea Therapeutics, Inc.

APRE · NASDAQ

$0.925

-1.06%

Adial Pharmaceuticals, Inc.

ADIL · NASDAQ

$0.2733

-7.54%

Kiora Pharmaceuticals, Inc.

KPRX · NASDAQ

$2.09

-2.11%

NeuroSense Therapeutics Ltd.

NRSN · NASDAQ

$0.8364

-6.02%

Cardio Diagnostics Holdings, Inc.

CDIO · NASDAQ

$3.09

-9.38%

Phio Pharmaceuticals Corp.

PHIO · NASDAQ

$1.08

-4.02%

Home

Home
Research
Strategy
Signal
Discover

Education

Academy
Tutorial
Strategy
Agent
Finance

Resources

Pricing
Referral
Partners
FAQ

Other

Terms
Privacy

Disclaimer: Content on AlphaPilot is for informational purposes only and does not constitute financial or investment advice. Past performance, including backtested results, is not indicative of future outcomes. AlphaPilot makes no guarantees regarding accuracy or reliability; use at your own risk.